Erratum: iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding (Proc. Natl. Acad. Sci. U.S.A. (2013) 110 (11433-11438) DOI: 10.1073/pnas.1302553110);iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 28, 2013, Pages 11433-11438

  Maretzky, Thorsten ^a   McIlwain, David R ^b,c   Issuree, Priya Darshinee A ^a,d   Li, Xue ^a,e   Malapeira, Jordi ^a   Amin, Sadaf ^a,e   Lang, Philipp A ^c   Mak, Tak W ^b   Blobel, Carl P ^a,d,e  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

^e Department of Obstetrics Gynecology   (United States)

Author keywords

ADAMs; Rhbdf1 2

Indexed keywords

ADAM PROTEIN; ADAM17 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IRHOM2 PROTEIN; KIT LIGAND 2; LYSOPHOSPHATIDIC ACID; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; FIBROBLAST; HEMATOPOIETIC CELL; IN VITRO STUDY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84879929720     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2112652118     Document Type: Erratum

References (34)

1. Black RA, et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385(6618):729-733. (Pubitemid 27098094)
2. Moss ML, et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385(6618):733-736. (Pubitemid 27098095)
3. Peschon JJ, et al. (1998) An essential role for ectodomain shedding in mammalian development. Science 282(5392):1281-1284. (Pubitemid 28524483)
4. Sahin U, et al. (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164(5):769-779. (Pubitemid 38282960)
5. Sunnarborg SW, et al. (2002) Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277(15):12838-12845. (Pubitemid 34952648)
6. Horiuchi K, et al. (2007) Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 179(5):2686-2689.
7. Issuree PD, et al. (2013) iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J Clin Invest 123(2):928-932.
8. Chalaris A, et al. (2010) Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med 207:1617-1624.
9. Franzke CW, et al. (2012) Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med 209(6):1105-1119.
10. Jackson LF, et al. (2003) Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22(11):2704-2716. (Pubitemid 36712367)
11. Sternlicht MD, et al. (2005) Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132(17):3923-3933. (Pubitemid 41410256)
12. Kawaguchi N, et al. (2007) Different ADAMs have distinct influences on Kit ligand processing: Phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19. J Cell Sci 120(Pt 6):943-952. (Pubitemid 46638509)
13. Swendeman S, et al. (2008) VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res 103(9):916-918.
14. Weskamp G, et al. (2010) Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res 106(5):932-940.
15. Horiuchi K, et al. (2007) Substrate selectivity of EGF-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 18:176-188. (Pubitemid 46066719)
16. Le Gall SM, et al. (2010) ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J Cell Sci 123(Pt 22):3913-3922.
17. Reddy P, et al. (2000) Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275(19):14608-14614. (Pubitemid 30339751)
18. Hall KC, Blobel CP (2012) Interleukin-1 stimulates ADAM17 through a mechanism independent of its cytoplasmic domain or phosphorylation at threonine 735. PLoS ONE 7(2):e31600.
19. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M (2012) Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335(6065):225-228.
20. McIlwain DR, et al. (2012) iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335(6065):229-232.
21. Adrain C, Freeman M (2012) New lives for old: Evolution of pseudoenzyme function illustrated by iRhoms. Nat Rev Mol Cell Biol 13(8):489-498.
22. Siggs OM, et al. (2012) iRhom2 is required for the secretion of mouse TNFα. Blood 119(24):5769-5771.
23. Lichtenthaler SF (2013) iRHOM2 takes control of rheumatoid arthritis. J Clin Invest 123(2):560-562.
24. Gschwind A, Hart S, Fischer OM, Ullrich A (2003) TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 22(10):2411-2421. (Pubitemid 36604980)
25. Prenzel N, et al. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402(6764):884-888.
26. Maretzky T, et al. (2011) Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat Commun 2:229.
27. Sanderson MP, et al. (2005) ADAM10 mediates ectodomain shedding of the beta-cellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J Biol Chem 280(3):1826-1837.
28. Le Gall S, et al. (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as TGFα, L-Selectin and TNFα. Mol Biol Cell 20:1785-1794.
29. Herrlich A, Klinman E, Fu J, Sadegh C, Lodish H (2008) Ectodomain cleavage of the EGF ligands HB-EGF, neuregulin1-beta, and TGF-alpha is specifically triggered by different stimuli and involves different PKC isoenzymes. FASEB J 22(12):4281-4295.
30. Hartmann M, Herrlich A, Herrlich P (2013) Who decides when to cleave an ectodomain? Trends Biochem Sci 38(3):111-120.
31. Mendelson K, Swendeman S, Saftig P, Blobel CP (2010) Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase- dependent crosstalk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways. J Biol Chem 285(32):25024-25032.
32. Blaydon DC, et al. (2012) RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet 90(2):340-346.
33. Schlöndorff J, Becherer JD, Blobel CP (2000) Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 347(Pt 1):131-138. (Pubitemid 30199050)
34. Nelson MD, Fitch DH (2011) Overlap extension PCR: An efficient method for transgene construction. Methods Mol Biol 772:459-470.